K Henry*1,2, D Kitch3, J Currier4, M Dube5, R Zackin3, R Parker 3, D Sprecher6, S Hammer7, and the Adult AIDS Clinical Trials Group and A5056 Team
1Univ. of Minnesota, Minneapolis, USA; 2Hennepin County Med. Ctr., Minneapolis, MN, USA; 3Harvard Sch. of Publ. Hlth., Boston, MA, USA; 4Univ. of California, Los Angeles, USA; 5Indiana Univ., Indianapolis, USA; 6Cleveland Clin., OH, USA; and 7Columbia Univ., New York, NY, USA
C Cipriano1, P Mercié1, E Balestre2, R Thiébaut3, J F Viallard1, F Dabis*3, and J L Pellegrin1
1Svc. de Med. Interne, Bordeaux, France; 2ISPED-GECSA, Univ. Bordeaux 2, France; and 3ISPED-GECSA, Univ. Bordeaux 2, France
P Maggi*1, G Epifani1, F Perilli1, A Lillo1, A Favia1, N Ladisa1, A Chirianni2, M Gargiulo2, S Ferraro2, R Maserati3, G Ravasi3, A Martignoni3, B Grisorio4, S Ferrara4, C Pellegrino4, and Prevaleat Study (Premature Vascular Lesions and Antiretroviral Therapy)
1Univ. of Bari, Italy; 2Cotugno Hosp., Naples, Italy; 3Univ. of Pavia, Italy; and 4Gen. Hosp., Foggia, Italy
U Iloeje*1, Y Yuan2, G L'Italien1, J Mauskopf3, S Holmberg4, A Moorman4, K Wood5, and R Moore6
1Bristol-Myers Squibb Co., Wallingford, CT, USA; 2Bristol-Myers Squibb Co., Plainsboro, NJ, USA; 3Res. Triangle Inst., Research Triangle Park, NC, USA; 4CDC, Atlanta, GA, USA; 5Cerner Corp., Kansas City, MO, USA; and 6Johns Hopkins Med. Inst., Baltimore, MD, USA
M G Law*1, A D'Arminio Monforte2,4, N Friis-Moller2,3, R Weber3,4, W El-Sadr5, P Reiss6, F Dabis7, L Morfeldt8, S De Wit9, C Pradier 10, G Calvo11, O Kirk12, C Sabin13, A N Phillips13, and J D Lundgren2
1AHOD, Natl. Ctr. in HIV Epidemiology and Clin. Res., UNSW, Sydney, Australia; 2Copenhagen HIV Prgm., Hvidovre Univ. Hosp., Denmark; 3SHCS, Univ. Hosp. Zurich, Switzerland; 4ICONA, L Sacco Hosp., Univ. of Milan, Milan, Italy; 5CPCRA, Columbia Univ./Harlem Hosp., New York, NY, USA; 6ATHENA, HIV Monitoring Fndn., Academic Med. Ctr., Amsterdam, The Netherlands; 7Aquitaine, Bordeaux Univ. Hosp., INSERM U593, Bordeaux, France; 8HivBivus, Karolinska Hosp., Stockholm, Sweden; 9Saint-Pierre Cohort, CHU Saint-Pierre Hosp., Brussels, Belgium; 10Nice Cohort, CHU Nice Hosp. de l'Archet, France; 11BASS, Autonomous Univ. of Barcelona, Spain; 12EuroSIDA, CHIP, Hvidovre Univ. Hosp., Copenhagen, Denmark; and 13Royal Free Ctr. for HIV Med., Royal Free and Univ. Coll., London, UK
A Mangili*1,2, J Gerrior1, A Tang1, D H O'Leary1,2, J F Polack1,2, E J Schaefer1,2, S L Gorbach1,2, and C A Wanke1,2
1Tufts Univ. Sch. of Med., Boston, MA, USA and 2Tufts-New England Med. Ctr., Boston, MA, USA
D Klein*1, L Hurley2, C Quesenberry2, and S Sidney2
1Kaiser Permanente, Hayward, CA, USA and 2Kaiser Permanente, Oakland, CA, USA
F Boccara*1, G Odi1, E Teiger1,4, E Di Angelantonio1, A Cohen1,2, G Barbarini2,3, G Barbaro3, and on behalf the FRench Italian Study on Coronary artery disease in AIDS patients (FRISCA-II).
1Saint Antoine Univ. Hosp., Assistance Publ.-Hosp. of Paris and Univ. of Paris VI, France; 2Univ. of Pavia, Italy; 3Univ. La Sapienza, Rome, Italy; and 4Henri Mondor Univ. Hosp., Assistance Publ.-Hosp. of Paris and Univ. of Paris XII, Creteil, France
A Khalsa*1, R Karim1, W Mack1, H Minkoff2, M Cohen3, M Young4, K Anastos5, R Greenblatt6, S Gange7, A Levine1, and Metabolic Working Group
1Univ. of Southern California, Los Angeles, USA; 2New York State Univ., Brooklyn, USA; 3Cook County Hosp., Chicago, IL, USA; 4Georgetown Univ., Washington, DC, USA; 5Montefiore Med. Ctr., Bronx, NY, USA; 6Univ. of California, San Francisco, USA; and 7Johns Hopkins Univ., Baltimore, MD, USA
